Paper34278178
Dual-Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular Carcinoma.
Chen K and 7 others. Hepatol Commun, 2021. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Dual-Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular Carcinoma. Papers, record 34278178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34278178
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dual-Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular Carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19228121 | Dual-specificity phosphatases: critical regulators with diverse cellular targets. | Biochem J | 2009 | https://conductscience.org/library/papers/19228121 | PubMed |
| 2 | 18330678 | Dual-specificity MAP kinase phosphatases (MKPs) and cancer. | Cancer Metastasis Rev | 2008 | https://conductscience.org/library/papers/18330678 | PubMed |
| 3 | 29624699 | Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. | Hepatology | 2018 | https://conductscience.org/library/papers/29624699 | PubMed |
| 4 | 24121300 | Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice. | J Vis Exp | 2013 | https://conductscience.org/library/papers/24121300 | PubMed |
| 5 | 28483913 | Antagonistic Interactions between Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Retinoic Acid Receptor Signaling in Colorectal Cancer Cells. | Mol Cell Biol | 2017 | https://conductscience.org/library/papers/28483913 | PubMed |
| 6 | 28450705 | The ETS family of oncogenic transcription factors in solid tumours. | Nat Rev Cancer | 2017 | https://conductscience.org/library/papers/28450705 | PubMed |
| 7 | 25678263 | The role of hepatic resection in the treatment of hepatocellular cancer. | Hepatology | 2015 | https://conductscience.org/library/papers/25678263 | PubMed |
| 8 | 18362927 | A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. | Mol Ther | 2008 | https://conductscience.org/library/papers/18362927 | PubMed |
| 9 | 23740750 | Pathview: an R/Bioconductor package for pathway-based data integration and visualization. | Bioinformatics | 2013 | https://conductscience.org/library/papers/23740750 | PubMed |
| 10 | 22238367 | DLK1 as a potential target against cancer stem/progenitor cells of hepatocellular carcinoma. | Mol Cancer Ther | 2012 | https://conductscience.org/library/papers/22238367 | PubMed |
| 11 | 22827337 | RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation. | Biochem J | 2012 | https://conductscience.org/library/papers/22827337 | PubMed |
| 12 | 31792430 | Tumour evolution in hepatocellular carcinoma. | Nat Rev Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/31792430 | PubMed |
| 13 | 30401534 | Dual-specificity MAP kinase phosphatases in health and disease. | Biochim Biophys Acta Mol Cell Res | 2019 | https://conductscience.org/library/papers/30401534 | PubMed |
| 14 | 26081571 | Orchestrating liver development. | Development | 2015 | https://conductscience.org/library/papers/26081571 | PubMed |
| 15 | 21269502 | VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. | BMC Bioinformatics | 2011 | https://conductscience.org/library/papers/21269502 | PubMed |
| 16 | 29880481 | Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment. | Cancer Res | 2018 | https://conductscience.org/library/papers/29880481 | PubMed |
| 17 | 16504415 | Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed? | Med Hypotheses | 2006 | https://conductscience.org/library/papers/16504415 | PubMed |
| 18 | 27560171 | Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. | Nat Protoc | 2016 | https://conductscience.org/library/papers/27560171 | PubMed |
| 19 | 18650514 | Sorafenib in advanced hepatocellular carcinoma. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18650514 | PubMed |
| 20 | 28474232 | ETS-targeted therapy: can it substitute for MEK inhibitors? | Clin Transl Med | 2017 | https://conductscience.org/library/papers/28474232 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42050913 | Dual-specificity phosphatase 14 inhibits the growth of cervical cancer cells by regulating the transforming growth factor-beta-activated kinase 1 and NOD-like receptor pyrin domain containing 3 inflammatory pathways. | J Int Med Res | 2026 | https://conductscience.org/library/papers/42050913 | PubMed |
| 41508037 | Single-cell multi-omics reveals DUSP9 as a key regulator of cancer stemness and a potential therapeutic target in hepatocellular carcinoma. | J Transl Med | 2026 | https://conductscience.org/library/papers/41508037 | PubMed |
| 41405398 | Mutual Exclusion Analysis Shows that DUSP9 Negatively Regulates PD-L1 Expression and Acts as a Target to Enhance Anti-PD-1 Efficacy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41405398 | PubMed |
| 41390797 | Multi-omic analysis of hepatocellular carcinoma reveals aberrant cis-regulatory changes and dysregulated retrotransposons with prognostic potential. | Commun Biol | 2025 | https://conductscience.org/library/papers/41390797 | PubMed |
| 40861803 | DUSP9 is Up-Regulated and Promotes Tumor Progression in Head and Neck Squamous Cell Carcinoma. | J Cancer | 2025 | https://conductscience.org/library/papers/40861803 | PubMed |
| 40005897 | Early Enhancement in Contrast-Enhanced Computed Tomography Is an Index of DUSP9, SLPI, ALDH1L2, and SLC1A1 Expression in Canine Hepatocellular Carcinoma: A Preliminary Study. | Vet Sci | 2025 | https://conductscience.org/library/papers/40005897 | PubMed |
| 38827026 | Oncogenes and tumor suppressor genes: functions and roles in cancers. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/38827026 | PubMed |
| 38720884 | Identifying specific TLS-associated genes as potential biomarkers for predicting prognosis and evaluating the efficacy of immunotherapy in soft tissue sarcoma. | Front Immunol | 2024 | https://conductscience.org/library/papers/38720884 | PubMed |
| 38644862 | miR-199a-5p targets DUSP14 to regulate cell proliferation, invasion and stemness in non-small cell lung cancer. | Heliyon | 2024 | https://conductscience.org/library/papers/38644862 | PubMed |
| 36980210 | Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer. | Cells | 2023 | https://conductscience.org/library/papers/36980210 | PubMed |
| 34925457 | Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma. | Front Genet | 2021 | https://conductscience.org/library/papers/34925457 | PubMed |
| 34830961 | The Cardiac Glycoside Deslanoside Exerts Anticancer Activity in Prostate Cancer Cells by Modulating Multiple Signaling Pathways. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34830961 | PubMed |
| 34768967 | DUSP9, a Dual-Specificity Phosphatase with a Key Role in Cell Biology and Human Diseases. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34768967 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34278178
GET https://conductscience.org/api/papers/v1/34278178/references?page=2